{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-031771","form_type":"8-K","ticker":"FHTX","cik":"0001822462","company_name":"Foghorn Therapeutics Inc.","filed_at":"2023-09-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.455791+00:00","generated_at":"2026-06-10T22:18:05.048421+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"low","headline":"Foghorn Therapeutics furnishes September 2023 corporate presentation","bullets":["Presentation highlights chromatin regulatory platform for precision oncology therapies.","No financial results, clinical data, or guidance changes disclosed in the exhibit.","Materials intended for investor meetings; no material new operational update provided."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-031771","json":"https://secwatch.observer/filing/0001628280-23-031771.json","markdown":"https://secwatch.observer/filing/0001628280-23-031771.md","text":"https://secwatch.observer/filing/0001628280-23-031771.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1822462/000162828023031771/0001628280-23-031771-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1822462/000162828023031771/fhtx-20230908.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T22:18:05.048421+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}